HackadaySynthetic Biology Creates Living ComputersHackadayMost people have at least a fuzzy idea of what DNA is. Ask about RNA, though, and unless you are talking to a biologist, you are likely to get even more handwaving. We hackers might have to rere… Continue reading
News-Medical.net |
Immunotherapy shows promise in treatment of Type 1 diabetes
News-Medical.net Around 1.25 million Americans are living with type 1 diabetes and 40000 new cases are detected each year. In this condition body’s own immune system attacks … Immunotherapy Promising for Diabetes: Study | The Scientist …The Scientist Immunotherapy for type I diabetes safe and well-tolerated, report …EPM Magazine |
Inverse |
Synthetic DNA Enables the Latest Horrifying Cybersecurity Threat
Inverse The electronic and molecular worlds are converging as scientists refine techniques for sequencing and synthesizing DNA (i.e. reading and writing DNA). Synthetic biology is an important field — advancements will help us fight diseases and disorders … Malware Stored in Synthetic DNA Can Take Over a PC, Researchers FindWall Street Journal (subscription) |
CBS News |
Study finds immunotherapy may prevent Type 1 diabetes | The …
The Seattle Times After a quarter-century of failed efforts to treat diabetes with an immune therapy, the experimental treatment appeared to quell the immune system’s assaults on … 8 things you need to know about diabetes right now – Yahoo Style UKYahoo Style UK |
|
Cancer Research UK, Biotecnol to Advance Solid Tumor Immunotherapy Into the Clinic
Genetic Engineering & Biotechnology News Cancer Research UK and Biotecnol said they will advance an immuno-oncology treatment for lung cancers and other solid tumors into early phase clinical trials, through a collaboration whose value was not disclosed. Cancer Research UK will support early … |
|
Cancer Research UK, Biotecnol to Advance Solid Tumor Immunotherapy Into the Clinic
Genetic Engineering & Biotechnology News Cancer Research UK and Biotecnol said they will advance an immuno-oncology treatment for lung cancers and other solid tumors into early phase clinical trials, through a collaboration whose value was not disclosed. Cancer Research UK will support early … |
OncLive |
Treating CINV Due to Immunotherapy and Targeted Therapy
OncLive Lee S. Schwartzberg, MD: Beth, you mentioned immunotherapy and chemotherapy, together, for non–small cell lung cancer. This is an exciting area. We’re at the 2017 ASCO Annual Meeting, and we’re going to hear a lot about immunotherapy. What’s your … |
OncLive |
Novel Immunotherapy Combinations for NSCLC
OncLive Vassiliki A. Papadimitrakopoulou, MD: ECHO-202 is a combination therapy of epacadostat and pembrolizumab in patients that are immunotherapy naïve with non–small cell lung cancer. Very early results are encouraging. We’re seeing response rates in the … |